Stefan Zimny1, Helmut Schatz, Martin Pfohl. 1. Evangelisches Krankenhaus Bethesda, Akademisches Lehrkrankenhaus der Universität Düsseldorf, Medizinische Klinik I, Duisburg, Germany. stefan.zimny@ruhr-uni-bochum.de
Abstract
OBJECTIVE: To assess the role of limited joint mobility (LJM) in causing abnormal high plantar pressures in the forefoot of diabetic patients with an at-risk foot. RESEARCH DESIGN AND METHODS: A total of 70 type 1 or type 2 diabetic patients and 30 control subjects participated in this cross-sectional study. Thirty-five diabetic patients with an at-risk foot, defined as a foot with neuropathy but without ulceration or previous ulceration, and 35 diabetic control subjects without neuropathy were selected for the subgroups. Joint mobility was assessed in the foot at the ankle and metatarsophalangeal I (first MTP) joints. Using the FastScan plantar pressure analyzer, the pressure-time integrals (PTIs) as dynamic variables were measured in each foot. The clinical assessment included standard measures of peripheral neuropathy. RESULTS: The mobility at the ankle and first MTP joint were significantly reduced in the foot-at-risk group compared with the diabetic control group and the control subjects (P < 0.0001). The PTIs were significantly higher in the foot-at-risk group compared with the two other groups (P < 0.0001). There was a strong inverse correlation between the mobility of the ankle or first MTP joint and the PTI of the diabetic patients (r = -0.67, P < 0.0001, and r = -0.71, P < 0.0001, respectively). The vibration perception threshold was positively correlated with the PTI of the diabetic patients (r = 0.44, P = 0.0001). CONCLUSIONS: Diabetic patients with an at-risk foot have reduced joint mobility and elevated PTIs on the plantar forefoot, placing them at risk for subsequent ulceration. Therefore, LJM may be a possible factor in causing high plantar pressures and may contribute to foot ulceration in the susceptible neuropathic at-risk foot.
OBJECTIVE: To assess the role of limited joint mobility (LJM) in causing abnormal high plantar pressures in the forefoot of diabeticpatients with an at-risk foot. RESEARCH DESIGN AND METHODS: A total of 70 type 1 or type 2 diabeticpatients and 30 control subjects participated in this cross-sectional study. Thirty-five diabeticpatients with an at-risk foot, defined as a foot with neuropathy but without ulceration or previous ulceration, and 35 diabetic control subjects without neuropathy were selected for the subgroups. Joint mobility was assessed in the foot at the ankle and metatarsophalangeal I (first MTP) joints. Using the FastScan plantar pressure analyzer, the pressure-time integrals (PTIs) as dynamic variables were measured in each foot. The clinical assessment included standard measures of peripheral neuropathy. RESULTS: The mobility at the ankle and first MTP joint were significantly reduced in the foot-at-risk group compared with the diabetic control group and the control subjects (P < 0.0001). The PTIs were significantly higher in the foot-at-risk group compared with the two other groups (P < 0.0001). There was a strong inverse correlation between the mobility of the ankle or first MTP joint and the PTI of the diabeticpatients (r = -0.67, P < 0.0001, and r = -0.71, P < 0.0001, respectively). The vibration perception threshold was positively correlated with the PTI of the diabeticpatients (r = 0.44, P = 0.0001). CONCLUSIONS:Diabeticpatients with an at-risk foot have reduced joint mobility and elevated PTIs on the plantar forefoot, placing them at risk for subsequent ulceration. Therefore, LJM may be a possible factor in causing high plantar pressures and may contribute to foot ulceration in the susceptible neuropathic at-risk foot.
Authors: Ericka N Merriwether; Mary K Hastings; Michael J Mueller; Kathryn L Bohnert; Michael J Strube; Darrah R Snozek; David R Sinacore Journal: Ann Gerontol Geriatr Res Date: 2016-07-22
Authors: Nick A Guldemond; Pieter Leffers; Geert H I M Walenkamp; Nicolaas C Schaper; Antal P Sanders; Fred H M Nieman; Lodewijk W van Rhijn Journal: BMC Endocr Disord Date: 2008-12-02 Impact factor: 2.763
Authors: David R Sinacore; David J Gutekunst; Mary K Hastings; Michael J Strube; Kathryn L Bohnert; Fred W Prior; Jeffrey E Johnson Journal: J Foot Ankle Res Date: 2013-03-25 Impact factor: 2.303